Faizul Azam

Buraydah, 51452, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

In Vitro Anti-Breast Cancer Effects of Tamarix aphylla-Derived Quercetin and In Silico Insights into Its Targeting of PIP4K2A.

In Vitro Anti-Breast Cancer Effects of Tamarix aphylla-Derived Quercetin and In Silico Insights into Its Targeting of PIP4K2A.

Journal: International journal of molecular sciences

Published: June 25, 2026

Protective role of Algerian Myrtus communis L. against pesticide mixture-induced reproductive toxicity: a combined experimental and molecular dynamics insights targeting steroidogenesis pathway.

Protective role of Algerian Myrtus communis L. against pesticide mixture-induced reproductive toxicity: a combined experimental and molecular dynamics insights targeting steroidogenesis pathway.

Journal: Xenobiotica; the fate of foreign compounds in biological systems

Published: May 12, 2026

Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities.

Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities.

Journal: International journal of molecular sciences

Published: March 14, 2026

Correction to: Arugula‑derived isothiocyanates as novel agents for a potential regulator of AKR1B10 protein in breast cancer: an integrated transcriptomic and molecular docking approach.

Correction to: Arugula‑derived isothiocyanates as novel agents for a potential regulator of AKR1B10 protein in breast cancer: an integrated transcriptomic and molecular docking approach.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: January 20, 2026

In silico Identification of Natural Compounds as Potential TrkA Inhibitors for Anticancer Drug Development.

In silico Identification of Natural Compounds as Potential TrkA Inhibitors for Anticancer Drug Development.

Journal: Iranian journal of pharmaceutical research : IJPR

Published: December 13, 2025

Arugula-derived isothiocyanates as novel agents for a potential regulator of AKR1B10 protein in breast cancer: an integrated transcriptomic and molecular docking approach.

Arugula-derived isothiocyanates as novel agents for a potential regulator of AKR1B10 protein in breast cancer: an integrated transcriptomic and molecular docking approach.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: November 05, 2025

Cracking the Sulfur Code: Garlic Bioactive Molecules as Multi-Target Blueprints for Drug Discovery.

Cracking the Sulfur Code: Garlic Bioactive Molecules as Multi-Target Blueprints for Drug Discovery.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 06, 2025

Computational study of chalcone-cyanopyrimidine hybrids as LSD1 inhibitors: Assessing the influence of FAD on binding affinity and inhibition.

Computational study of chalcone-cyanopyrimidine hybrids as LSD1 inhibitors: Assessing the influence of FAD on binding affinity and inhibition.

Journal: Biochemistry and biophysics reports

Published: July 07, 2025

Identifying a novel class of lead compounds for monoacylglycerol lipase inhibition: an integrated computational study.

Identifying a novel class of lead compounds for monoacylglycerol lipase inhibition: an integrated computational study.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)

Published: April 04, 2025

Monotherapy vs combination therapy evaluation of FDA-approved TKIs targeting PDGFR for the treatment of thyroid cancer.

Monotherapy vs combination therapy evaluation of FDA-approved TKIs targeting PDGFR for the treatment of thyroid cancer.

Journal: Journal of biomolecular structure & dynamics

Published: March 10, 2025

Preclinical and Molecular Docking Insights into the Chemopreventive Role of Fenugreek Seed Extract in a Murine Model of Colorectal Cancer.

Preclinical and Molecular Docking Insights into the Chemopreventive Role of Fenugreek Seed Extract in a Murine Model of Colorectal Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 05, 2025

Insights into the Therapeutic Targets and Molecular Mechanisms of Eruca sativa Against Colorectal Cancer: An Integrated Approach Combining Network Pharmacology, Molecular Docking and Dynamics Simulation.

Insights into the Therapeutic Targets and Molecular Mechanisms of Eruca sativa Against Colorectal Cancer: An Integrated Approach Combining Network Pharmacology, Molecular Docking and Dynamics Simulation.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 03, 2025

Showing 1-12 of 68

Last Updated: 09/26/2026